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Abstract
Background: Cervical incompetence is an important cause of miscarriage and premature birth and polycystic ovary
syndrome is a heterogeneous endocrine disorder that is the most common cause of anovulatory infertility and
eugonadotrophic hypogonadism. By now, it is still debated whether women with PCOS have an increased risk of
miscarriage and there have been no studies about the pregnancy outcomes of cervical incompetence patients with
PCOS.
Methods: The following clinical data of cervical incompetence patients with/without PCOS who were treated
between September 2006 and September 2013 were retrospectively analysed: onset gestational age, termination
gestational age, pregnancy outcome, co-morbid insulin resistance (IR) in PCOS patients, the influence of IR, co-
morbid hyperandrogenism (HA) in PCOS patients, and the influence of HA. The independent samples t-test and chi-
square trend test were used to analyse the data.
Results: A total of 178 singleton pregnancy cases with cervical incompetence were identified. The average onset
gestational age was 23.9 ± 4.3 weeks, and the average termination gestational age was 32.5 ± 5.5 weeks. Of these 178
singleton pregnancy cases, 40 (22.5 %) ended in miscarriage, 82 (46.1 %) ended in preterm birth, and 56 (31.5 %) ended
in term birth. Eighty cases (44.9 %) exhibited PCOS co-morbidity, and those cases had an average onset gestational age
of 22.3 ± 3.8 weeks and an average termination gestational age of 31.2 ± 5.7 weeks, which were both significantly
different from those of the non-PCOS group (both P < 0.001). Compared with the non-PCOS group (15.3 % miscarriage,
48.0 % preterm birth, and 36.7 % term birth), the PCOS group exhibited worse pregnancy outcomes (31.3 %
miscarriage, 43.8 % preterm birth, and 25 % term birth) (P = 0.01). Among the 80 PCOS patients, 45 (56.3 %) exhibited
co-morbid IR, and the IR group exhibited significantly worse pregnancy outcomes than the non-IR group (P = 0.03).
Among the 80 PCOS patients, 54 cases (67.5 %) exhibited co-morbid HA, and there was no statistical difference on the
pregnancy outcomes between the two groups. The multivariate logistic regression model revealed that PCOS was
significantly correlated with miscarriage (OR: 3.72, 95 % CI: 1.37–10.13).
Conclusions: The cervical incompetence patients with co-morbid PCOS exhibited earlier onset gestational ages, earlier
termination gestational ages and worse pregnancy outcomes. For patients with co-morbid insulin resistance, the
pregnancy outcomes were worse than expected.
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Background
Cervical incompetence is an important cause of miscarriage
and premature birth and its definition is imprecise. It is
sometimes defined as a biochemical and biomechanical
problem (structural “weakness” due to acquired or inherent
cervical tissue defects), sometimes as a clinical problem
(the event/outcome of asymptomatic mid-trimester preg-
nancy loss), but usually the phrase is meant to encompass
both [1]. The aetiology and pathogenesis of cervical incom-
petence remain unclear [2].
Cervical competence is now believed to change serially
during the pregnancy process. Congenital dysplasia of the
cervix, a lack of elastic fibres in the cervix, and a reduced
collagen/smooth muscle ratio can lead to cervical incom-
petence. The causes of acquired cervical incompetence in-
clude mechanical injury, trauma, and biochemical factors.
The length of the remaining cervix after conization is re-
lated to the incidence of cervical incompetence [3].
Although some women diagnosed with cervical in-
competence actually have poor cervical integrity, the
cervical anatomy of most such women is normal [4].
The generally accepted cause of cervical incompetence is
premature cervical ripening, which leads to miscarriage/
preterm birth due to subclinical infection, local inflam-
mation, hormonal effects, and genetic factors [4].
Patients with cervical incompetence often do not ex-
perience contractions or obvious clinical symptoms be-
fore miscarriage or premature birth, which decreases the
chance of providing treatment. Emergency cervical cerc-
lage is sometimes performed in patients with dilation of
the cervix, but infections and postoperative contractions
with subsequent miscarriage often occur with this pro-
cedure [5].
Polycystic ovary syndrome (PCOS) is a heterogeneous
endocrine disorder that is the most common cause of an-
ovulatory infertility and eugonadotrophic hypogonadism
[6–8]. The typical symptoms of PCOS include hyperandro-
genism(HA), ovulation dysfunction, and polycystic ovaries.
Approximately 50–70 % of PCOS cases are complicated by
insulin resistance (IR). IR is a critical characteristic of meta-
bolic syndrome [9], which is defined as insulin hyporeactiv-
ity and reduced absorption and utilization of glucose. Thus,
in metabolic syndrome patients, insulin secretion increases,
causing hyperinsulinemia and the exhaustion of the β cells
in pancreatic islets [10]. Currently, IR is considered a basic
pathological feature of PCOS, and higher concentrations of
insulin can increase androgen levels and affect fertilization
and implantation in PCOS patients [11].
Previous studies found that women with PCOS exhib-
ited a clinically significant increased risk of pregnancy
compared with controls [12]. Data which were not ad-
justed for BMI demonstrated that women with PCOS
presented a 3–4-fold increased risk of developing pre-
eclampsia, a 3-fold increased risk of gestational diabetes
and 2-fold higher chance of premature delivery. But it is
still debated whether women with PCOS have an in-
creased risk of miscarriage compared with women with-
out PCOS [12]. And by now, there have been no studies
about the pregnancy outcomes of cervical incompetence
patients with PCOS.
Previous studies found that androgens were crucial for
cervical remodelling and myometrial ripening, but they
failed to show a consistent relationship between either
androgen excess or androgen deficiency and pregnancy
outcomes. And the underlying mechanism by which an-
drogens impact pregnancy outcomes has not been fully
understood [13].
In this study, we retrospectively analysed the clinical data
of cervical incompetence patients treated at the Depart-
ment of Obstetrics and Gynecology, Peking University
Third Hospital during the last 7 years to explore the clinical
characteristics and pregnancy outcomes of cervical incom-
petence patients, particularly cervical incompetence pa-
tients with PCOS, IR and HA.
Methods
Data sources
The clinical data of patients who received routine prenatal
care at our hospital and were diagnosed with cervical in-
competence were collected between September 2006 and
September 2013. This study was approved by the Ethics
Committee of Peking University Third Hospital (No.
2014204). Written informed consent was not obtained
from the participants because this was a retrospective
study. All clinical records/information were anonymized
and de-identified prior to analysis. The inclusion criterion
was singleton pregnancy with cervical incompetence. The
exclusion criteria were the following: i) dysplasia or mal-
formation of the reproductive system (such as a unicornu-
ate uterus, septate uterus, or double uterus), ii) infection,
iii) multiple pregnancy, iv) a history of cervical conization,
and v) a history of cervical incompetence. The enrolled
patients were treated with bed rest, progesterone, or cerc-
lage according to their gestational week, cervical length,
and internal os width. We analysed the onset gestational
ages (defined here as the gestational age at the onset of
cervical incompetence), termination gestational ages and
pregnancy outcomes of these patients. We divided the pa-
tients into PCOS and non-PCOS groups and compared
their clinical characteristics. Then, we divided the patients
with PCOS into IR and non-IR groups and compared
their clinical characteristics. Similarly, we divided the pa-
tients with PCOS into HA and non-HA groups and com-
pared their clinical characteristics.
The diagnosis of cervical incompetence depends on
clinical symptoms and ultrasonic results [14, 15]. The
diagnosis of PCOS was based on the Rotterdam 2003 cri-
teria [16], which requires the presence of at least two of
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the following three features: i) oligo- and/or anovulation,
ii) clinical and/or biochemical signs of hyperandrogenism,
and iii) polycystic ovaries; the Rotterdam 2003 criteria also
require the exclusion of other identifiable endocrine disor-
ders, such as late-onset congenital adrenal hyperplasia,
hyperprolactinemia, thyroid dysfunction, and neoplastic
androgen secretion. IR level was evaluated using the
Homeostatic Model Assessment (HOMA-IR) index calcu-
lated before pregnancy [17],HOMA-IR = fasting insu-
lin(lU/ml) × fasting glucose(mmol/L)/22.5,and if HOMA-
IR > 3.6, IR was diagnosed. HA before pregnancy is de-
fined as excessive levels of androgens and their associated
effects, except adrenal hyperplasia. Miscarriage was de-
fined as foetal delivery at <28 weeks of gestational age in
this study, and preterm delivery was defined as foetal de-
livery at ≥28 weeks but <37 weeks of gestational age.
Data analysis
The data were captured from the Hospital Information
System and were managed by Microsoft Excel 2013. All
analyses were performed using SPSS version 18.0 (SPSS
Inc., Chicago, IL, USA). The quantitative parameters that
were normally distributed were expressed as χ2 values and
were tested by the independent samples t test. Proportions
were used to describe the characteristics and pregnancy
outcomes of the patients. The Pearson’s Chi-square test
and Chi-square trend test were applied to examine pro-
portions between groups. The factors that may have af-
fected pregnancy outcomes were analysed by multivariate
logistic regression. A 2-sided p value of less than 0.05 was
considered significant.
Results
A total of 31,466 patients delivered at Peking University
Third Hospital during the 7-year study period. Among
these patients, 178 were diagnosed with cervical incompe-
tence (0.6 %); the age range of those patients was 21 to
40 years, with an average age of 31.0 ± 3.9 years. Of the 158
patients (88.8 %) that were primiparous, 45 (25.3 %) had
undergone assisted reproductive technology (ART) treat-
ment and 30 (16.9 %) had co-morbid diabetes mellitus
(DM)/gestational diabetes mellitus (GDM). We divided the
patients into PCOS (80/178) and non-PCOS (98/178)
groups. Age, parity and the frequencies of ART treatment
and DM/GDM comorbidity were not significantly different
between the two groups (Table 1).
For the 178 included patients, the average onset gesta-
tional age was 23.9 ± 4.3 weeks, and the average termin-
ation gestational age was 32.5 ± 5.5 weeks. Forty
pregnancies (22.5 %) ended in miscarriage, 82 (46.1 %)
ended in preterm birth and 56 (31.5 %) ended in term
birth. In the PCOS group, the average onset gestational
age and termination gestational age were significantly
lower (P < 0.01), and the pregnancy outcome was
significantly worse (P < 0.05) than in the non-PCOS
group (Table 2). The rate of cervical cerclage in the
PCOS group and non-PCOS group was 56.3 % and
44.9 % respectively, and there was no statistical differ-
ence (P > 0.05). (Table 2)
Women in PCOS group were further divided into co-
morbid IR and non-IR groups for comparison. Among the
80 PCOS patients, 45 cases (56.3 %) had the co-morbidity of
IR. For the IR group, the onset gestational age and termin-
ation gestational age were significantly lower (P = 0.03, 0.01),
and the pregnancy outcome was significantly worse com-
pared with the non-IR group (P= 0.03) (Table 3). similarly,
women in PCOS group were further divided into co-morbid
HA and non-HA groups for comparison. Among the 80
PCOS patients, 54 cases (67.5 %) exhibited co-morbid HA,
and there was no statistical difference on the pregnancy out-
comes between the two groups (P = 0.22) (Table 4).
To detect whether there were potential confounding
factors in our study, a multivariate logistic regression
analysis was conducted with miscarriage as the
dependent variable and PCOS, DM/GDM, ART, age,
BMI and onset gestational age as the independent vari-
ables. As shown in Table 5, only PCOS had a significant
effect on bad pregnancy outcomes (miscarriage) (OR =
3.02, 95 % CI:1.07–8.48).
Discussion
The present retrospective study revealed that patients with
cervical incompetence co-morbid with PCOS exhibited earl-
ier onset and termination gestational age as well as worse
pregnancy outcomes than non-PCOS patients. PCOS pa-
tients with an IR co-morbidity exhibited earlier onset and
termination gestational age. In addition, PCOS was signifi-
cantly correlated with miscarriage, whereas DM/GDM,
ART, age and BMI were not.




PCOS(n = 80) Non-PCOS(n = 98) p
Age x  sð Þ 31.0 ± 3.9 31.5 ± 4.1 30.6 ± 3.8 0.11a
Parity (n/%)
Primiparity 158(88.8) 72(90.0) 86(87.8) 0.64b
Multiparity 20(11.2) 8(10.0) 12(12.2)
Received ART (n/%)
Yes 45(25.3) 24(30.0) 21(21.4) 0.19b
No 133(74.7) 56(70.0) 77(78.6)
Co-morbid DM/GDM (n/%)
Yes 30(16.9) 17(21.3) 13(13.3) 0.16b
No 148(83.1) 63(78.7) 85(86.7)
BMI 24.2 ± 3.4 26.8 ± 3.0 22.1 ± 2.0 <0.01
aIndependent samples t test
b Chi-square test
Wang et al. BMC Pregnancy and Childbirth  (2016) 16:308 Page 3 of 6
At present, there is no standard for the diagnosis and
treatment of cervical incompetence. The diagnosis of
cervical insufficiency is challenging due to the lack of
objective findings and clear diagnostic criteria for this
disease. The diagnosis is based on a history of painless
cervical dilation after the first trimester with subsequent
expulsion of the pregnancy in the second trimester, typ-
ically before 24 weeks of gestation, and a lack of contrac-
tions, labour or any other clear pathology (e.g., bleeding,
infection, etc.). In our study, all patients were hospital-
ized because of painless cervical shortening or dilation.
Although the onset gestational age of some patients was
greater than 24 weeks, all patients presented with pain-
less cervical dilation without contractions, bleeding or
any symptoms of infection and did not have threatened
miscarriage or threatened premature birth at admission.
According to the literature, the morbidity of cervical in-
competence in pregnant women is 0.05 % ~ 1 % [18].
Our study, which excluded patients with multiple
pregnancies and reproductive system malformation, re-
vealed an incidence of cervical incompetence of 0.56 %.
Previous studies have reported that pregnant women
with PCOS are susceptible to perinatal complications re-
gardless of the definition of perinatal complications
used, including elevated risk of gestational diabetes,
pregnancy-induced hypertension, pre-eclampsia, preterm
delivery and Caesarean section [19, 20]. Consistent with
the findings of those studies, our results revealed that
the co-morbidity of PCOS in cervical incompetence pa-
tients had exacerbating effects with respect to the onset
and termination gestational ages and pregnancy out-
comes. Furthermore, our logistic regression analysis con-
firmed the correlation of PCOS with miscarriage. Our
results were also consistent with those of Farinelli et al.
[21], who found no correlation between BMI and cer-
vical incompetence. For patients with PCOS, cervical in-
competence presents in an earlier gestational week,
suggesting that early detection of cervical length may
help in the early diagnosis and treatment of cervical in-
competence. But unfortunately, in this study, some data
of the cervical length was missing, and this is a
limitation.









Onset gestational age x  sð Þ 23.9 ± 4.3 22.3 ± 3.8 25.1 ± 4.1 <0.01a
Termination gestational
age x  sð Þ
32.5 ± 5.5 31.2 ± 5.7 33.6 ± 5.1 <0.01a
Pregnancy outcomes (n/%)
Miscarriage 40(22.5) 25(31.3) 15(15.3) 0.03b
Preterm birth 82(46.0) 35(43.2) 47(48.0)
Term birth 56(31.5) 20(25.0) 36(36.7)
Pregnancy outcomes 2 (n/%)
Miscarriage (less than
24 weeks)
16(22.5) 12(15.0) 4(4.1) 0.02b
Preterm birth 106(46.1) 48(60.0) 58(59.2)
Term birth 56(31.5) 20(25.0) 36(36.7)
Cervical cerclage 89(50.0) 45(56.3) 44(44.9) >0.05
aIndependent samples t test
b Chi-square test
1Miscarriage was defined as foetal delivery at <28 weeks of gestational age
2 Miscarriage was defined as foetal delivery at <24 weeks of gestational age






Onset gestational age x  sð Þ 21.4 ± 3.6 23.3 ± 3.9 0.03a
Termination gestational
age x  sð Þ
29.8 ± 5.9 33.0 ± 5.0 0.01a
Pregnancy outcomes (n/%)
Miscarriage 19(42.2 %) 6(17.1 %) 0.03b
Preterm birth 17(37.8 %) 18(51.4 %)
Term birth 9(20.0 %) 11(31.4 %)
aIndependent samples t test
b Chi-square trend test






Onset gestational age x  sð Þ 22.2 ± 3.4 22.4 ± 4.6 0.80
Termination gestational age x  sð Þ 31.0 ± 6.0 31.8 ± 5.3 0.56
Pregnancy outcomes (n/%)
Miscarriage (less than 28) 19(35.2 %) 6(23.1 %) 0.22
Preterm birth 20(37.0 %) 15(57.7 %)
Term birth 15(27.8 %) 5(19.2 %)
aIndependent samples t test
b Chi-square trend test
Table 5 Results of different multivariate logistic regression
models performed to determine the relationship between PCOS
and miscarriage
Crude OR Adjusted OR1 Adjusted OR2
OR 95%CI OR 95%CI OR 95%CI
PCOS 2.52* 1.22–5.20 3.72* 1.37–10.13 3.02* 1.07–8.48
DM/GDM 1.06 0.15–2.69 0.94 0.36–2.51 0.87 0.33–2.30
ART 1.36 0.62–2.98 1.23 0.54–2.80 1.49 0.65–3.45
Age - 0.98 0.89–1.07 0.95 0.86–1.04
BMI - 0.92 0.80–1.06 0.95 0.82–1.09
Onset gestational
Age
- - - 0.90* 0.81–0.99
Model 1 adjusted for age and BMI by multivariate logistic regression, model 2
adjusted for age, BMI and onset gestational age by multivariate
logistic regression
* indicated p < 0.05
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Previous studies have investigated the high incidence
of miscarriage in women with PCOS and identified vari-
ous aspects of PCOS, including hyperinsulinemia and
other endocrine disorders, that are involved in the cor-
relation of PCOS with miscarriage. In our study, PCOS
patients with an IR co-morbidity exhibited earlier onset
gestational age and earlier termination gestational age,
indicating that these women warrant more aggressive
treatment to prevent cervical incompetence, such as be-
ginning monitoring at an earlier gestational age and in-
creasing the monitoring frequency. We speculate that
the high incidence of miscarriage in PCOS patients with
the co-morbidity of IR maybe due to the following fac-
tors: IR may aggravate PCOS conditions, and IR may in-
duce a glucose metabolism disorder that directly affects
cervical incompetence, resulting in an adverse outcome.
More research is needed to clarify the mechanisms
through which IR increases the incidence of miscarriage.
In this study, we found no statistical difference on the
pregnancy outcomes between the HA and non-HA
groups. But the limitation is that we failed to get the
data of androgen concentrations throughout gestation.
Previous studies have found that androgens were crucial
for cervical remodelling and myometrial ripening which
may lead to preterm birth, but they failed to show a con-
sistent relationship between either androgen excess or
androgen deficiency and pregnancy outcomes. Further
investigation of the underlying mechanisms of androgen
action on cervical remodelling and myometrial contract-
ility is needed.
Our study included 178 patients with cervical incom-
petence who delivered at our hospital during the past
7 years. Due to the long study duration and large num-
bers of cases, our findings are representative of the
Chinese population. Our study has the following limita-
tions: first, clinical data showed that all the 80 PCOS pa-
tients had examinations before pregnancy and they were
diagnosed as PCOS according to the Rotterdam 2003
criteria, and the remaining 98 patients were diagnosed
as non-PCOS with regular menstrual cycles and no clin-
ical symptoms of androgen excess. There may be a little
bias. Second, our hospital does not routinely screen for
IR in women without PCOS; therefore, we did not have
data regarding IR in non-PCOS patients. Thus, we can-
not conclude whether the effect of IR on pregnancy out-
comes is dependent on PCOS. Third, according to our
medical treatment conditions, miscarriage is defined as
foetal delivery at <28 weeks of gestational age in China,
which is different from that in the developed countries
such as America (<24 weeks) and England (<20 weeks).
Compared with the non-PCOS group, the miscarriage
rate (<28 weeks and <24 weeks) in the PCOS group was
significantly higher. Due to few samples, the data of mis-
carriage (<20 weeks) rate was not calculated. Fourth, the
estimated odds ratios (ORs) in the multistate analysis
maybe have bias due to relatively small sample number.
In summary, it is very important for pregnant women
with PCOS to undergo regular ultrasound examinations.
In recent years, patients at our hospital with histories of
cervical incompetence, recurrent miscarriages at middle
gestational ages and cervical cone biopsy surgery have
received two types of treatment. One is prophylactic cer-
vical cerclage at the beginning of the middle gestational
weeks, and the other is repetitive ultrasound examina-
tions for cervical length every 2–4 weeks from the be-
ginning of the third gestational month. For patients
lacking a history of any of those disorders, we typically
monitor cervical length via routine ultrasound examina-
tions performed at 11–14 weeks, 21–24 weeks and 28–
32 weeks of pregnancy. Based on the findings of our
study, we suggest regularly monitoring cervical length
during pregnancy for PCOS patients to achieve an early
diagnosis and early treatment of cervical incompetence.
Obviously this monitoring strategy will be more expen-
sive and will require more medical resources, so cost-
benefit and cost effectiveness studies are necessary.
Conclusion
We found that patients with cervical incompetence and
PCOS exhibited a poor prognosis and that the prognosis
was even worse for patients with the additional co-
morbidity of IR. Thus, in the clinic, early monitoring
and early therapy will help to improve the prognosis of
patients with both PCOS and IR. Furthermore, treat-
ment of cervical incompetence requires both obstetric
and endocrine input. We hope that our research will at-
tract the attention of brilliant scientists in other subject
areas and will help direct future relevant studies.
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